Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0050 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0050 |
Peptide Name | Deltorphan |
PEPTIDE SEQUENCE (1-letter) | YAFDVVG |
PEPTIDE SEQUENCE (3-letter) | Tyr-(D)Ala-Phe-Asp-Val-Val-Gly-NH2 |
N-terminal modification | NA |
C-terminal modification | Amide group is attached |
Chemical modification | NA |
Peptide Length | 7 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | Chemically synthesized |
SMILES | N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)O |
Cell Line | NA |
In vitro CONCENTRATION | NA |
In vitro METHOD | NA |
In vitro RESULT | NA |
ANIMAL MODEL | C57BL6 mice |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | Intravenous |
In vivo METHOD | Confocal microscopy |
In vivo RESULT | Presence of engineered nano particles within the brain parenchyma with particular focus on hippocamp |
ACTION | Opioid-derived peptides featured by specific helix-like conformation as possible ligands to engineer |
TRANSPORT TYPE | NA |
SUBCELLULAR LOCALISATION | CNS parenchyma |
COMBINATION | Comined |
PHYSICAL CONDITION | NA |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 32479916 |